MULTRYS (Cupric Sulfate; Manganese Sulfate; Selenious Acid; Zinc Sulfate) Patent Expiration, LOE Window & CMS Spending

MULTRYS (Cupric Sulfate; Manganese Sulfate; Selenious Acid; Zinc Sulfate) by Daiichi Sankyo: FDA Orange Book core substance LOE 2041-07-01, 0 AB generics, $0 2024 CMS Part D & Medicaid spend, and 10 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorDaiichi Sankyo
FDA Application & PathwayN209376 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE Date2041-07-01
Last Listed Patent or Exclusivity Date2041-07-01
Orange Book Patents (*PED Extensions)15 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)10 WAC filings (max 31.1% 2-yr change)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Daiichi Sankyo across sibling Meru public-data platforms.